Suppr超能文献

SARS-CoV-2 的神经嗜性及其神经病理学改变:与其他冠状病毒的相似性。

Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses.

机构信息

Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang, No. 155, North Nanjing Street, Heping District, Shenyang, 110001, Liaoning, PR China.

Institute of Clinical Medicine - Neurology, University of Eastern Finland, Yliopistonranta 1C (PO Box 1627), 70211, Kuopio, Finland; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Yliopistonranta 1C (PO Box 1627), 70211, Kuopio, Finland.

出版信息

Neurosci Biobehav Rev. 2020 Dec;119:184-193. doi: 10.1016/j.neubiorev.2020.10.012. Epub 2020 Oct 19.

Abstract

A novel coronavirus (SARS-CoV-2) emerged from Wuhan, China, and spread quickly around the world. In addition to fever, cough and shortness of breath, it was confirmed that the patients also have manifestations towards the central nervous system (CNS), especially those critically ill ones. In this review, we will discuss how SARS-CoV-2 gain access to the CNS and the possible consequences. Both SARS-CoV-2 and SARS-CoV-1 in 2002 share the same receptor angiotensin-converting enzyme 2 (ACE2), which can be found in the brain and mediate the disease process. Both direct attack of SARS-CoV-2 and the abnormal immune response in the CNS would contribute to the disease. Also, there is a relationship between SARS-CoV-2 and the occurrence of acute cerebrovascular diseases.

摘要

一种新型冠状病毒(SARS-CoV-2)源自中国武汉,并迅速在全球范围内传播。除了发热、咳嗽和呼吸急促外,还证实患者还表现出中枢神经系统(CNS)症状,尤其是重症患者。在这篇综述中,我们将讨论 SARS-CoV-2 如何进入 CNS 以及可能产生的后果。2002 年的 SARS-CoV-2 和 SARS-CoV-1 都使用相同的受体血管紧张素转换酶 2(ACE2),该受体存在于大脑中,并介导疾病过程。SARS-CoV-2 的直接攻击和 CNS 中的异常免疫反应都会导致疾病。此外,SARS-CoV-2 与急性脑血管疾病的发生之间存在关联。

相似文献

1
Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses.
Neurosci Biobehav Rev. 2020 Dec;119:184-193. doi: 10.1016/j.neubiorev.2020.10.012. Epub 2020 Oct 19.
2
Update on neurological manifestations of COVID-19.
Life Sci. 2020 Sep 15;257:118063. doi: 10.1016/j.lfs.2020.118063. Epub 2020 Jul 9.
3
Emerging neurotropic features of SARS-CoV-2.
J Mol Cell Biol. 2021 Dec 30;13(10):705-711. doi: 10.1093/jmcb/mjab044.
4
Neuroinvasion and neurotropism of severe acute respiratory syndrome coronavirus 2 infection.
Curr Opin Microbiol. 2024 Jun;79:102474. doi: 10.1016/j.mib.2024.102474. Epub 2024 Apr 13.
5
SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19.
Brain Pathol. 2021 Nov;31(6):e13013. doi: 10.1111/bpa.13013. Epub 2021 Aug 13.
6
Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2.
Drug Discov Ther. 2021 Jan 23;14(6):262-272. doi: 10.5582/ddt.2020.03106. Epub 2020 Dec 31.
7
SARS-CoV-2 invasion of the central nervous: a brief review.
Hosp Pract (1995). 2021 Aug;49(3):157-163. doi: 10.1080/21548331.2021.1887677. Epub 2021 Mar 1.
8
Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
J Neurosci Res. 2021 Mar;99(3):750-777. doi: 10.1002/jnr.24752. Epub 2020 Nov 20.

引用本文的文献

1
Diffusion tensor imaging features of white matter pathways in the brain after COVID-19 infection.
Radiologie (Heidelb). 2025 Jan 28. doi: 10.1007/s00117-024-01414-w.
2
Clinical and Functional Effects of Rehabilitation of Patients after COVID-19 Infection.
J Clin Med. 2024 May 31;13(11):3257. doi: 10.3390/jcm13113257.
5
6
SARS-CoV-2 infection and cognition in community-dwelling and nursing home residents in southern Switzerland.
Brain Behav Immun Health. 2023 Nov 7;35:100701. doi: 10.1016/j.bbih.2023.100701. eCollection 2024 Feb.
8
Identifying cerebral microstructural changes in patients with COVID-19 using MRI: A systematic review.
Brain Circ. 2023 Mar 24;9(1):6-15. doi: 10.4103/bc.bc_77_22. eCollection 2023 Jan-Mar.
9
Association between serologically confirmed COVID-19 infection and cognitive functioning in community dwelling older adults.
Front Neurol. 2023 Mar 21;14:1093852. doi: 10.3389/fneur.2023.1093852. eCollection 2023.

本文引用的文献

1
The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains.
Front Neurol. 2021 Jan 20;11:573095. doi: 10.3389/fneur.2020.573095. eCollection 2020.
3
Neurological Involvement in COVID-19 and Potential Mechanisms: A Review.
Neurocrit Care. 2021 Jun;34(3):1062-1071. doi: 10.1007/s12028-020-01049-4.
4
Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study.
Stroke Vasc Neurol. 2020 Sep;5(3):279-284. doi: 10.1136/svn-2020-000431. Epub 2020 Jul 2.
5
Comment on "Encephalopathy in patients with COVID-19: A review".
J Med Virol. 2021 Jan;93(1):149-150. doi: 10.1002/jmv.26238. Epub 2020 Jul 11.
6
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.
Lancet Psychiatry. 2020 Oct;7(10):875-882. doi: 10.1016/S2215-0366(20)30287-X. Epub 2020 Jun 25.
8
Encephalopathy in patients with COVID-19: A review.
J Med Virol. 2021 Jan;93(1):206-222. doi: 10.1002/jmv.26207. Epub 2020 Jul 11.
9
Neurobiology of COVID-19.
J Alzheimers Dis. 2020;76(1):3-19. doi: 10.3233/JAD-200581.
10
Neuropathological Features of Covid-19.
N Engl J Med. 2020 Sep 3;383(10):989-992. doi: 10.1056/NEJMc2019373. Epub 2020 Jun 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验